Registered Nurse - NICU - Hopewell - Full-Time - NIGHTS Capital HealthRegistered Nurse - NICU - Hopewell - Full-Time - NIGHTSHopewell, NJ$43.90–$59.69 / hourRequires NIH Stroke Scale Certification (or must obtain by end of orientation) AND 8 hours of Stroke related Continuing Nursing Education (CNE) contact hours annually if assigned to: Critical Care, Intermediate Care Unit, Emergency Department, Neuro Units, Cardiology Inpatient at Hopewell, Peds ED, PACU, Interventional Radiology, CNI, Observation. CPR Requirements: Requires ACLS (or must obtain within 6 months of hire date) if assigned to: Critical Care/Intermediate/Telemetry, Emergency Rooms, Pediatrics/Pediatrics Emergency Room, Labor & Delivery, Surgical Services (not to include Perioperative), Interventional Procedures, Observation.
Registered Nurse - Medical Care - Trenton - Full-Time - NIGHTS Capital HealthRegistered Nurse - Medical Care - Trenton - Full-Time - NIGHTSTrenton, NJ$43.90–$59.69 / hourRequires NIH Stroke Scale Certification (or must obtain by end of orientation) AND 8 hours of Stroke related Continuing Nursing Education (CNE) contact hours annually if assigned to: Critical Care, Intermediate Care Unit, Emergency Department, Neuro Units, Cardiology Inpatient at Hopewell, Peds ED, PACU, Interventional Radiology, CNI, Observation. CPR Requirements: Requires ACLS (or must obtain within 6 months of hire date) if assigned to: Critical Care/Intermediate/Telemetry, Emergency Rooms, Pediatrics/Pediatrics Emergency Room, Labor & Delivery, Surgical Services (not to include Perioperative), Interventional Procedures, Observation.
NewRegistered Nurse - Operating Room - Hamilton Surgery Center - Full-time - Day Capital HealthRegistered Nurse - Operating Room - Hamilton Surgery Center - Full-time - DayHopewell, New JerseyRequires NIH Stroke Scale Certification (or must obtain by end of orientation) AND 8 hours of Stroke related Continuing Nursing Education (CNE) contact hours annually if assigned to: Critical Care, Intermediate Care Unit, Emergency Department, Neuro Units, Cardiology Inpatient at Hopewell, Peds ED, PACU, Interventional Radiology, CNI, Observation, Hospital at Home. Requires ATCN or TNCC (or must obtain within 1 year of hire) AND 8 hours of Trauma related Continuing Nursing Education (CNE) contact hours annually if assigned to: RMC ICU/CCU, RMC Surgical Trauma Unit, RMC PACU, Emergency Department (all campuses).
Registered Nurse (FT) Prism Vision GroupRegistered Nurse (FT)Moorestown Twp, New Jersey$27.98–$58.11 / hourThe Registered Nurse provides skilled nursing care using knowledgeable evaluation and assessment techniques in planning for care and treatment of individual patient needs. • Utilizes professional nursing judgement, takes action to implement the nursing care plan, and resolves identifiable issues before they become a problem/incident/event.
*$10K SIGN ON BONUS* Registered Nurse Flex - Central Resource Office - FT - Evening Capital Health*$10K SIGN ON BONUS* Registered Nurse Flex - Central Resource Office - FT - EveningHopewell, New JerseyRequires NIH Stroke Scale Certification (or must obtain by end of orientation) AND 8 hours of Stroke related Continuing Nursing Education (CNE) contact hours annually if assigned to: Critical Care, Intermediate Care Unit, Emergency Department, Neuro Units, Cardiology Inpatient at Hopewell, Peds ED, PACU, Interventional Radiology, CNI, Observation. Requires ATCN or TNCC (or must obtain within 1 year of hire) AND 8 hours of Trauma related Continuing Nursing Education (CNE) contact hours annually if assigned to: RMC ICU/CCU, RMC Surgical Trauma Unit, RMC PACU, Emergency Department (all campuses).
Behavioral Safety Assistant II Penn MedicineBehavioral Safety Assistant IIWest Chester, PAtPatient Communication: Interact with patients to reduce aggression, agitation, or confusion, using personalized interventions suited to their specific needs, as instructed by the Registered Nurse or behavioral health providers. tPatient Transfers: Perform safe patient transfers using proper ergonomics and patient-handling equipment, including transfers from bed to chair, wheelchair, or stretcher.
NewBehavioral Safety Assistant II: 3rd shift per diem Penn MedicineBehavioral Safety Assistant II: 3rd shift per diemWest Chester, PAtPatient Communication: Interact with patients to reduce aggression, agitation, or confusion, using personalized interventions suited to their specific needs, as instructed by the Registered Nurse or behavioral health providers. tPatient Transfers: Perform safe patient transfers using proper ergonomics and patient-handling equipment, including transfers from bed to chair, wheelchair, or stretcher.
Behavioral Safety Assistant II Per Diem 2nd Shift Penn MedicineBehavioral Safety Assistant II Per Diem 2nd ShiftWest Chester, PAtPatient Communication: Interact with patients to reduce aggression, agitation, or confusion, using personalized interventions suited to their specific needs, as instructed by the Registered Nurse or behavioral health providers. tPatient Transfers: Perform safe patient transfers using proper ergonomics and patient-handling equipment, including transfers from bed to chair, wheelchair, or stretcher.
CRNA – Jefferson Einstein Philadelphia (Full or Part-Time) * $75,000 Sign-On Bonus Thomas Jefferson UniversityCRNA – Jefferson Einstein Philadelphia (Full or Part-Time) * $75,000 Sign-On BonusPhiladelphia, PennsylvaniaJefferson is more than 65,000 people strong, dedicated to providing the highest-quality, compassionate clinical care for patients; making our communities healthier and stronger; preparing tomorrow's professional leaders for 21st-century careers; and creating new knowledge through basic/programmatic, clinical and applied research. Jefferson Health , nationally ranked as one of the top 15 not-for-profit health care systems in the country and the largest provider in the Philadelphia and Lehigh Valley areas, serves patients through millions of encounters each year at 32 hospitals campuses and more than 700 outpatient and urgent care locations throughout the region.
CRNA - Jefferson Einstein Philadelphia (Full or Part-Time) * $75,000 Sign-On Bonus Thomas Jefferson UniversityCRNA - Jefferson Einstein Philadelphia (Full or Part-Time) * $75,000 Sign-On BonusPhiladelphia, PAJefferson is more than 65,000 people strong, dedicated to providing the highest-quality, compassionate clinical care for patients; making our communities healthier and stronger; preparing tomorrow's professional leaders for 21st-century careers; and creating new knowledge through basic/programmatic, clinical and applied research. Jefferson Health, nationally ranked as one of the top 15 not-for-profit health care systems in the country and the largest provider in the Philadelphia and Lehigh Valley areas, serves patients through millions of encounters each year at 32 hospitals campuses and more than 700 outpatient and urgent care locations throughout the region.
Certified Registered Nurse Anesthetist Cooper University HospitalCertified Registered Nurse AnesthetistCamden, NJBoard Certified as a Certified Registered Nurse AnesthetistCurrent, valid State of New Jersey RN Current, valid State of New Jersey APN licenseCurrent, valid certification from National Board of Certification and Recertification for Nurse Anesthetists (NBCRNA) Current, valid DEA license Current BLS, ACLS, & PALS certifications. Laurel:• Cooper Digestive Health Center (5-bed)Voorhees:• Voorhees Surgery Center (5-bed)Moorestown:• Moorestown Surgery Center (9-bed)Willingboro:• BMA Cooper Specialty Care GI (1-bed)Cape Regional:• Main Hospital Operating Room (2-bed)• Surgery Center (4-bed).
Registered Nurse - Emergency Room | Day Shift, $2,484/Week Philadelphia, PA 19124 Pulse Clinical AllianceRegistered Nurse - Emergency Room | Day Shift, $2,484/Week Philadelphia, PA 19124Philadelphia, PennsylvaniaOnboarding Bonuses Healthcare is an ever-changing landscape and the professionals at Pulse Clinical are ready to navigate those changes to benefit our employees and contractors seeking meaningful employment in the healthcare industry! Healthcare professionals working for us are guided and inspired by ensuring the best fit for our employees and providing great support services, benefits, and highly competitive pay!
Registered Nure (Transitional Care Unit) - Per Diem (Night Shift) Penn MedicineRegistered Nure (Transitional Care Unit) - Per Diem (Night Shift)Plainsboro, NJ$49.96–$68.99 / hourPenn Medicine is dedicated to our tripartite mission of providing the highest level of care to patients, conducting innovative research, and educating future leaders in the field of medicine. The split flow model allows emergency services to continue delivering care to arriving patients while the newly admitted patient is handed off to the TCU RN.
Outpatient Registered Nurse Acadia Healthcare Co IncOutpatient Registered NursePhiladelphia, PAMust possess a current Registered Nurse (RN) license as required by the state of employment or be eligible to practice nursing in accordance with state requirements One year of nursing experience; previous psychiatric, mental, behavioral, or substance use nursing experience a plus CPR and de-escalation and restraint certification required (training available upon hire and offered by facility). For the past 75 years, this hospital has been offering life-saving and life-changing treatment for children, adolescents, adults, and older adults alike, and supplies a full continuum of care designed to meet the various treatment needs of all who require top-notch mental and behavioral healthcare services.
Registered Nurse (7pm - 7am) University Health Services IncRegistered Nurse (7pm - 7am)PAOperating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located all over the U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. Avoid and Report Recruitment Scams At UHS and all our subsidiaries, our Human Resources departments and recruiters are here to help prospective candidates by matching skill set and experience with the best possible career path at UHS and our subsidiaries.
Registered Nurse (7am - 7pm) University Health Services IncRegistered Nurse (7am - 7pm)PAOperating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located all over the U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. Avoid and Report Recruitment Scams At UHS and all our subsidiaries, our Human Resources departments and recruiters are here to help prospective candidates by matching skill set and experience with the best possible career path at UHS and our subsidiaries.
Registered Nurse - House Supervisor PRN University Health Services IncRegistered Nurse - House Supervisor PRNPAOperating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located all over the U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. Brooke Glen offers unique and individualized programming for adolescents and adults that sets us apart from many other treatment facilities, and our tenured leadership team includes a seasoned nursing department.
NewNursing Assistant - Neuro Stroke Unit Nights Penn MedicineNursing Assistant - Neuro Stroke Unit NightsWest Chester, PAEducation Specialization: Equivalent Experience: •And 0-1 years Training and/or experience at an acute care facility or student nurse with hospital based clinical experience •0-1 years Previous secretarial skills or healthcare experience. Penn Medicine is dedicated to our tripartite mission of providing the highest level of care to patients, conducting innovative research, and educating future leaders in the field of medicine.
NewNursing Assistant - Days, Full Times Penn MedicineNursing Assistant - Days, Full TimesWest Chester, PAEducation Specialization: Equivalent Experience: •And 0-1 years Training and/or experience at an acute care facility or student nurse with hospital based clinical experience •0-1 years Previous secretarial skills or healthcare experience. Penn Medicine is dedicated to our tripartite mission of providing the highest level of care to patients, conducting innovative research, and educating future leaders in the field of medicine.
Senior Director, Global Value Access and Pricing, NSCLC Revolution Medicines IncSenior Director, Global Value Access and Pricing, NSCLCRedwood City, CARemote$232,000–$290,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As the Global Value & Access lead on Disease Area Strategy Teams and governance forums, the Senior Director influences clinical development, indication sequencing, lifecycle management, launch planning, and business development decisions to maximize long-term asset value and sustainable patient access.
Associate Director, Business Operations Revolution Medicines IncAssociate Director, Business OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The role is ideal for a Associate Director -level professional who thrives on execution, can drive several projects in parallel, can navigate a matrix environment, and brings strong project leadership, communication and change management experience.
Director, Toxicology Pliant Therapeutics IncDirector, ToxicologySouth San Francisco, CA$232,000–$256,000 / yearThis role provides strong scientific and intellectual leadership across cross-functional teams, partners closely with internal stakeholders and external vendors, and represents nonclinical safety in interactions with global regulatory authorities. Make an Impact: Demonstrates strong ownership of nonclinical safety strategy and execution, driving programs forward with urgency while ensuring high-quality, regulatory-ready results that directly influence pipeline advancement.
Associate Director, Clinical Quality Assurance Revolution Medicines IncAssociate Director, Clinical Quality AssuranceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Senior Director, Global Value Access and Pricing, NSCLC Revolution MedicinesSenior Director, Global Value Access and Pricing, NSCLCRedwood City, CaliforniaRemote$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As the Global Value & Access lead on Disease Area Strategy Teams and governance forums, the Senior Director influences clinical development, indication sequencing, lifecycle management, launch planning, and business development decisions to maximize long-term asset value and sustainable patient access.
Associate Director, Global Healthcare Compliance Operations Revolution MedicinesAssociate Director, Global Healthcare Compliance OperationsRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Lead implementation, enhancement, validation, and lifecycle management of systems supporting HCP/HCO engagements, advisory boards, speaker programs, grants and sponsorships, third-party due diligence, transparency reporting, monitoring and auditing activities, compliance training and certifications.
Associate Director, Clinical Quality Assurance Revolution MedicinesAssociate Director, Clinical Quality AssuranceRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Business Operations Revolution MedicinesAssociate Director, Business OperationsRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The role is ideal for a Associate Director –level professional who thrives on execution, can drive several projects in parallel, can navigate a matrix environment, and brings strong project leadership, communication and change management experience.
Associate Director, Biostatistics Clinical Late Stage Revolution MedicinesAssociate Director, Biostatistics Clinical Late StageRedwood City, California$186,000–$233,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Alliance Management Revolution MedicinesDirector, Alliance ManagementRedwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Executive Director, GCP QA Good Clinical Practice, Quality Assurance Revolution Medicines IncExecutive Director, GCP QA Good Clinical Practice, Quality AssuranceRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Minimum of 15 years of experience in the pharmaceutical or biotechnology industry, including at least 10 years in GCP QA or clinical quality leadership roles, with demonstrated experience leading and hosting regulatory inspections (e.g., FDA BIMO, EMA, MHRA, PMDA).
Regional Insights and Engagement Director, Lung, Central Rockies Revolution Medicines IncRegional Insights and Engagement Director, Lung, Central RockiesRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Executive Director, Stanford Institute for Research in the Social Sciences Stanford UniversityExecutive Director, Stanford Institute for Research in the Social SciencesStanford, CA$164,402–$211,171 / yearIn this era of burgeoning social-science research, the Stanford Institute for Research in the Social Sciences (IRiSS) facilitates first-rate interdisciplinary collaborations, trains the next generation of scholars, and incubates medium- to long-term research projects to address critical social challenges. The ED is responsible for the operational effectiveness of: (a) four research support services, (b) two graduate fellowship programs, (c) startup and administrative support and oversight for six interdisciplinary research centers, (d) a small portfolio of NSF funded research projects, and (e) three to four new research ventures.
Director, Global Medical Affairs - GI Oncology Revolution Medicines IncDirector, Global Medical Affairs - GI OncologyRedwood City, CA$211,000–$264,000 / yearKey aspects of this role include the following: support the development and execution of a Healthcare Professional (HCP) engagement strategy to gather insights that shape internal programs; act as the medical representative on cross-functional teams; serve as a therapeutic area content expert; and support medical affairs functions as needed. Provides medical support in scientific engagement activities with key external stakeholders through organizing and participating in advisory boards, study investigator interactions, congress activities, and peer-to-peer discussions, communicating scientific insights to internal teams to help drive strategy.
Regional Insights and Engagement Director, Northeast Revolution Medicines IncRegional Insights and Engagement Director, NortheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Senior Director, Global Medical Affairs - GI Oncology Revolution Medicines IncSenior Director, Global Medical Affairs - GI OncologyRedwood City, CA$244,000–$305,000 / yearProvides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, studies investigator interactions, congress activities, and peer-to-peer discussions with the goal of communicating scientific insights to internal teams to drive strategy. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, GLP Quality Assurance Revolution Medicines IncDirector, GLP Quality AssuranceRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Director, Good Laboratory Practice Quality Assurance (GLP QA) is responsible for ensuring Good Laboratory Practices (GLP) compliance at RevMed and external vendors contracted to perform regulated work on behalf of RevMed including all GLP vendors.
NewNational Sales Director, Cell Therapy & Transplant CareDxNational Sales Director, Cell Therapy & TransplantBrisbane, CARemote$335,000–$360,000 / yearThrough our innovative portfolio of molecular diagnostics, digital health solutions, AI-powered data and analytics, and patient support services, we partner with healthcare providers, patients, and biopharma organizations to help inform clinical decision-making and improve patient outcomes. Partner closely with Marketing, Medical Affairs, Customer Experience, Sales Operations, Training, and Product Management teams to develop customer-centric solutions, generate market insights, and ensure successful execution of commercial objectives.
Director, Investment Analyst (Early Career) Program ProLogisDirector, Investment Analyst (Early Career) ProgramSan Francisco, CA$155,000–$213,000 / yearThe Director of our Investment Analyst Program (IAP) plays a mission-critical role in developing the next generation of investment and business professionals while ensuring the organization is strategically resourced to support Prologis's investment, development and corporate priorities. This position leads the Investment Analyst Program (IAP) and serves as a key talent developer within the organization, ensuring our teams are strategically resourced across acquisitions, developments, and corporate initiatives.
Senior Director, Global Medical Affairs - GI Oncology Revolution MedicinesSenior Director, Global Medical Affairs - GI OncologyRedwood City, California$244,000–$305,000 / yearProvides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, studies investigator interactions, congress activities, and peer-to-peer discussions with the goal of communicating scientific insights to internal teams to drive strategy. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Regional Insights and Engagement Director, Lung, Southeast Revolution MedicinesRegional Insights and Engagement Director, Lung, SoutheastRedwood City, CaliforniaRemote$231,000–$254,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Regional Insights and Engagement Director, Lung, Southeast Revolution Medicines IncRegional Insights and Engagement Director, Lung, SoutheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Executive Director, GCP QA (Good Clinical Practice, Quality Assurance) Revolution MedicinesExecutive Director, GCP QA (Good Clinical Practice, Quality Assurance)Redwood City, California$265,000–$331,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Minimum of 15 years of experience in the pharmaceutical or biotechnology industry, including at least 10 years in GCP QA or clinical quality leadership roles, with demonstrated experience leading and hosting regulatory inspections (e.g., FDA BIMO, EMA, MHRA, PMDA).
Regional Insights and Engagement Director, Lung, Central Rockies Revolution MedicinesRegional Insights and Engagement Director, Lung, Central RockiesRedwood City, CaliforniaRemote$231,000–$254,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Regional Insights and Engagement Director, Northeast Revolution MedicinesRegional Insights and Engagement Director, NortheastRedwood City, CaliforniaRemote$231,000–$254,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Director, GLP Quality Assurance Revolution MedicinesDirector, GLP Quality AssuranceRedwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Director, Good Laboratory Practice Quality Assurance (GLP QA) is responsible for ensuring Good Laboratory Practices (GLP) compliance at RevMed and external vendors contracted to perform regulated work on behalf of RevMed including all GLP vendors.
Director, Global Medical Affairs – GI Oncology Revolution MedicinesDirector, Global Medical Affairs – GI OncologyRedwood City, California$211,000–$264,000 / yearKey aspects of this role include the following: support the development and execution of a Healthcare Professional (HCP) engagement strategy to gather insights that shape internal programs; act as the medical representative on cross-functional teams; serve as a therapeutic area content expert; and support medical affairs functions as needed. Provides medical support in scientific engagement activities with key external stakeholders through organizing and participating in advisory boards, study investigator interactions, congress activities, and peer-to-peer discussions, communicating scientific insights to internal teams to help drive strategy.
Associate Director, Medical Analytics and Exploratory Data Science Revolution Medicines IncAssociate Director, Medical Analytics and Exploratory Data ScienceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This role will play a critical part in the design, analysis, and interpretation of exploratory data analyses, scientific publications, real-world evidence (RWE), post-marketing research, and health economics and outcomes research (HEOR) studies.
Independent Restaurant Culinary Director Compass Group North AmericaIndependent Restaurant Culinary DirectorSouth San Francisco, CA$130,000–$140,000 / yearThis is a rare opportunity to oversee a diverse and evolving portfolio of chef-driven concepts, including a vibrant market hall, multiple cafés, bars and lounges, an upscale California-French casual dining restaurant, an Italian concept, a seafood concept, coffee shops, a food truck, and expansive conference and meeting spaces. We are deeply committed to sustainability, local farm-to-fork sourcing, seasonality, responsible purchasing, and building meaningful relationships with farmers, fisheries, artisans, and regional producers.
Senior Director, Executive & Enterprise Communications Revolution Medicines IncSenior Director, Executive & Enterprise CommunicationsRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Senior Director, Executive & Enterprise Communications will serve as a trusted communications advisor to the CEO and select senior leaders while leading enterprise internal communications across a growing global organization.
Associate Director, Commercial Regulatory Affairs Revolution Medicines IncAssociate Director, Commercial Regulatory AffairsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As part of the Regulatory Affairs function, the Associate Director will work under supervision to provide strategic regulatory advice on advertising/promotion and medical materials to the US organization for assigned products in accordance with business goals and objectives, FDA regulations/guidances, pharma guidelines, and company policy.